A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

NCT04626921 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: CNM-Au8

Sponsor

Clene Nanomedicine

Collaborators

[object Object]